{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:28:27Z","timestamp":1768318107056,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.humpath.2014.01.017","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T21:31:45Z","timestamp":1391635905000},"page":"1192-1198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia\/lymphoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Hongjing","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineyoshi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyofumi","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2014.01.017_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2014.01.017_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BC20070078","article-title":"MicroRNAs: small molecules with big roles: C. elegans to human cancer","volume":"100","author":"Kato","year":"2008","journal-title":"Biol Cell"},{"key":"10.1016\/j.humpath.2014.01.017_bb0015","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/S1470-2045(12)70073-6","article-title":"microRNAs in cancer management","volume":"13","author":"Kong","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2014.01.017_bb0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0030","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"281","article-title":"Adult T-cell leukemia\/lymphoma","author":"Ohshima","year":"2008"},{"key":"10.1016\/j.humpath.2014.01.017_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1349-7006.2010.01767.x","article-title":"Immunopathogenesis of lymphoma: focus on CCR4","volume":"102","author":"Ishida","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2014.01.017_bb0050","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.1158\/0008-5472.CAN-08-0769","article-title":"Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1","volume":"68","author":"Yeung","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2014.01.017_bb0055","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2008-11-189845","article-title":"Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-1 adult T-cell leukemia","volume":"113","author":"Bellon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2014.01.017_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1742-4690-5-100","article-title":"MicroRNAs miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1 transformed T lymphocytes","volume":"5","author":"Pichler","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.humpath.2014.01.017_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2014.01.017_bb0070","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/ijc.25115","article-title":"MicroRNA miR-146a is induced by HTLV-1 Tax and increases the growth of HTLV-1 infected T-cells","volume":"130","author":"Tomita","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2014.01.017_bb0075","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.canep.2012.07.002","article-title":"Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia","volume":"36","author":"Ishihara","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0040","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25 high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0090","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2014.01.017_bb0100","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1158\/0008-5472.CAN-07-5019","article-title":"Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer","volume":"67","author":"Sempere","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2014.01.017_bb0105","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ejca.2009.04.039","article-title":"Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation","volume":"45","author":"Cho","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2014.01.017_bb0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6605742","article-title":"The functional significance of microRNA-145 in prostate cancer","volume":"103","author":"Zaman","year":"2010","journal-title":"Bri J Cancer"},{"key":"10.1016\/j.humpath.2014.01.017_bb0115","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2010.09.023","article-title":"Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis","volume":"54","author":"Gao","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0120","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1349-7006.2007.00618.x","article-title":"Downregulation of microRNAs-143 and -145 in B-cell malignancies","volume":"98","author":"Akao","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2014.01.017_bb0125","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0130","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nor107","article-title":"Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas","volume":"13","author":"Fischer","year":"2011","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.humpath.2014.01.017_bb0135","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/carcin\/bgr036","article-title":"MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer","volume":"32","author":"Suh","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2014.01.017_bb0140","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0808042106","article-title":"p53 represses c-Myc through induction of the tumor suppressor miR-145","volume":"106","author":"Sachdeva","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2014.01.017_bb0145","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/febs.12236","article-title":"The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer","volume":"280","author":"Hart","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.humpath.2014.01.017_bb0150","doi-asserted-by":"crossref","first-page":"e54652","DOI":"10.1371\/journal.pone.0054652","article-title":"MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:34:10Z","timestamp":1758645250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817714000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0046817714000537"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2014.01.017","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia\/lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2014.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}